Savient Pharmaceuticals Names John P. Hamill Chief Financial Officer

by Benzinga Staff
September 24, 2012 7:33 AM | 20 seconds read | Make a Comment

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Savient Pharmaceuticals,Inc. (Nasdaq: SVNT) today announced the appointment of John P. Hamill asSenior Vice President & Chief Financial Officer effective today.  Mr. Hamillbrings over 25 years of global financial and administrative operationalexperience to Savient with a specialized background in pharmaceutical serviceindustry.  Mr. Hamill will be responsible for all financial and accountingfunctions of the Company and will report directly to Lou Ferrari, Presidentand Chief Executive Officer of Savient.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsManagement

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.